News

Publication of Half-year report 2024

OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim…

Oslo, Norway, July 17, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held an Extraordinary General Meeting today, July…

OSLO, NORWAY – July 15, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that the…

OSLO, NORWAY – 04 July 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…

Oslo, Norway, July 3, 2024 – Notice is hereby served that an extraordinary general meeting of Genetic Analysis AS (the…

OSLO, NORWAY – July 1, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that an…

Genetic Analysis AS (“GA” or the “Company”) is pleased to announce that it has successfully placed a directed issue and…

OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant…

OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt…

OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board…

OSLO, NORWAY – 31 May 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board…

OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby publishes the…

in Genetic Analysis AS Oslo, Norway, May 15, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual…

Oslo, Norway, April 24, 2024 – Notice is hereby served that the annual general meeting of Genetic Analysis AS (the…

OSLO, NORWAY – 19 April 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…